|Event Name||Harvard 2016 Navigating the American Pharmaceutical Sector: Policy, Politics, Pricing, and Payment
Monday, December 05, 2016
Thursday, December 08, 2016
|Description||By participating in this program, you will learn to:
• Understand the US health care and pharmaceutical sectors as well as the context in which they developed
• Identify the impact of different payment structures and payer relationships on US health care spending and market pricing
• Navigate the FDA’s approval process
• Perform relevant measurable and objective analyses necessary to support decision making
• Determine challenges and opportunities facing the innovative biopharmaceutical industry
• Recognize the key potential pathways for distributing pharmaceutical products in the US
Who Should Participate
• Pharmaceutical sector employees from innovative/brand name manufacturers, generic manufacturers and biologics.
• International pharmaceutical companies interested in entering the US market.
• Employees from pharmaceutical benefit managers, including those involved in stakeholder relationships and pricing/discount practices.
• Insurance company employees responsible for managing the pharmaceutical benefit.
• Employees from pharmacies, including large pharmacy chains, independent pharmacies and specialty pharmacies.
• Government employees from a variety of stakeholders, including the FDA, CMS, state Medicaid departments and employees benefit purchasing groups.
• Large employer human resources benefit managers.
• Provider groups interested in the role of prescription drugs in recent reforms, such as Accountable Care Organizations and bundled payment programs.
• Other participants interested in expanding knowledge of pharmaceutical regulation, policy and practices in the US, including academics.
• Recognize the structure and key components of the US pharmaceutical sector.
• Gain a working knowledge of pharmaceutical regulations in the US surrounding approval, patents and generic entry and post marketing requirements.
• Analyze the politics of pharmaceutical policy in the US through analysis of pharmaceutical reforms, the ACA, and other major reforms.
• Obtain an appreciation for the differences between Medicare, Medicaid and private payer pharmaceutical reimbursement methodologies.
• Examine the issue of high cost prescription drugs and potential solutions, including policies and innovations in payment reform.